Key characteristics of patients with CLL at baseline and outcomes during follow-up
| Key characteristics . | Not received IgRT . | Received any IgRT . |
|---|---|---|
| No. of patients, n (%) | 5464 (87.9) | 753 (12.1) |
| Follow-up, mean (SD), y | 4.7 (3.4) | 6.9 (3.8) |
| Diagnosed before 2015 | 1659 (30.4) | 466 (61.9) |
| Mean age at diagnosis, y | 71.0 (12.0) | 69.5 (10.9) |
| Age at diagnosis, n (%) | ||
| <60 years | 942 (17.2) | 137 (18.2) |
| 60-69 years | 1404 (25.7) | 209 (27.8) |
| ≥70 years | 3118 (57.1) | 407 (54.1) |
| Sex, Female, n (%) | 1919 (36.6) | 262 (34.8) |
| CCI year prior to diagnosis,∗ n (%) | ||
| Unknown (no hospitalizations year prior to diagnosis) | 2255 (41.3) | 227 (30.1) |
| Mild | 2677 (49.0) | 457 (60.7) |
| Moderate | 322 (5.9) | 58 (7.7) |
| Severe | 210 (3.8) | 11 (1.5) |
| Key characteristics . | Not received IgRT . | Received any IgRT . |
|---|---|---|
| No. of patients, n (%) | 5464 (87.9) | 753 (12.1) |
| Follow-up, mean (SD), y | 4.7 (3.4) | 6.9 (3.8) |
| Diagnosed before 2015 | 1659 (30.4) | 466 (61.9) |
| Mean age at diagnosis, y | 71.0 (12.0) | 69.5 (10.9) |
| Age at diagnosis, n (%) | ||
| <60 years | 942 (17.2) | 137 (18.2) |
| 60-69 years | 1404 (25.7) | 209 (27.8) |
| ≥70 years | 3118 (57.1) | 407 (54.1) |
| Sex, Female, n (%) | 1919 (36.6) | 262 (34.8) |
| CCI year prior to diagnosis,∗ n (%) | ||
| Unknown (no hospitalizations year prior to diagnosis) | 2255 (41.3) | 227 (30.1) |
| Mild | 2677 (49.0) | 457 (60.7) |
| Moderate | 322 (5.9) | 58 (7.7) |
| Severe | 210 (3.8) | 11 (1.5) |
SD, standard deviation.
CCI could not be calculated in patients without any hospitalizations the year before diagnosis (unknown: no hospitalizations year prior to diagnosis); for all other characteristics there were no missing data.